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ABSTRACT
Objective: We investigated whether the presence of 
unilateral or bilateral upper tract obstruction could 
accurately predict advanced cancer stage.
Methods: Six hundred and ten patients with bladder 
cancer entered into the tumor registries of our 
institutions between January 1990 and December
1994. The median patient age was 64 years (range 35 
to 80). A total 75 (12%) patients had unilateral or 
bilateral hydronephrosis on an IVP at the time of initial 
diagnosis of the bladder cancer. Preoperative 
screening included physical examination, chest 
radiograph, complete blood count, blood urea 
nitrogen, creatinin, electrolyte analysis and IVP. 
Furthermore, patients were usually evaluated by bone 
scan and computerized tomography (CT). The 
diagnosis of transitional cell carcinoma was made 
by cystoscopy and transurethral resection of the 
tumor. Staging transurethral resection was done in all 
cases.
Results: During a 5-year period 75 of 610 patients 
with carcinoma of the bladder had ureteral obstruction 
on excretory urography at the time of the initial 
diagnosis. Preoperative IVP revealed unilateral and 
bilateral hydronephrosis in 55 (73%) and 20 (27%) 
patients, respectively. Pathological staging revealed 
predominantly pT1 lesions for patients with unilateral 
obstruction. There were 30 (55%) patients with pT1, 10 
(18%) with pT2, and 15 (27%) with pT3. Pathological 
staging revealed predominantly pT2 lesions for 
patients with bilateral obstruction. Pathological stage 
was pT2 in 10 (50%) cases, pT3 in 5 (25%), and pT4 
in 5 (25%).
Conclusion: IVP can be used in staging because 
hydronephrosis may Indicate the presence of a
muscle-invasive bladder cancer, especially, bilateral 
hydronephrosis was strongly associated with 
advanced stage disease.
K e y  W o rd s : Bladder cancer, excretory urography, 
clinical stage, pathological stage, transurethral 
resection.
IN T R O D U C T IO N
Transitional cell carcinoma of the bladder is the 
second most common genitourinary malignancy. 
There are 54.000 new cases per year and 12.500 
bladder cancer related deaths (1). Bladder cancer is 
most accurately staged by transurethral resection 
(TUR) of the bladder lesion. Pathological stage has 
been accepted as the gold standard to predict the 
survival of patients with bladder cancer (2,3). 
Excretory urography is commonly obtained early in the 
evaluation of the biadder tumor patient. Given the 
potential field change nature of urethelial neoplasm, 
this study is certainly warranted to exclude 
concomitant upper tract disease. Despite the 
development of new Imaging techniques, clinical 
staging for bladder cancer continues to be inaccurate
(3). We investigated whether the presence of unilateral 
or bilateral upper tract obstruction could in excretory 
urography (IVP) accurately predict advanced cancer 
stage.
M E TH O D S
Six hundred and ten patients with bladder cancer 
entered into the tumor registries of our institutions 
between January 1990 and December 1994. The 
median patient age was 64 years (range 35 to 80). A
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total of 75 (12%) patients had unilateral or bilateral 
hydronephrosis on an IVP at the time of initial 
diagnosis of the bladder cancer. Preoperative 
screening included physical examination, chest 
radiograph, complete blood count, blood urea 
nitrogen, creatinin, electrolyte analysis and IVP. 
Furthermore, patients were usually evaluated by bone 
scan and computerized tomography (CT). The 
diagnosis of transitional cell carcinoma was made by 
cystoscopy and transurethral resection of the tumor. 
Staging transurethral resection was done in all cases. 
The tumors were graded according to the World Health 
Organization Grading System and staged by TNM 
Classification (4,5).
RESULTS
Six hundred and ten patients with bladder cancer who 
underwent transurethral resection at our institutions 
between January 1990 and December 1994, were 
retrospectively reviewed. During a 5-year period 75 of 
610 patients with carcinoma of the bladder had 
ureteral obstruction on excretory urography at the time 
of the initial diagnosis. Preoperative IVP revealed 
unilateral and bilateral hydronephrosis in 55 (73%) and 
20 (27%) patients, respectively. Of the patients 
presenting with unilateral obstruction 64% had left 
ureteral obstruction and 36% had right ureteral 
obstruction. Pathological staging revealed 
predominantly pT1 lesions for patients with unilateral 
obstruction. There were 30 (55%) patients with pT 1,10 
(18%) with pT2, and 15 (27%) with pT3. Pathological 
staging revealed predominantly pT2 lesions for 
patients with bilateral obstruction. Pathological 
stage was pT2 in 10 (50%) cases, pT3 in 5 (25%), and 
pT4 in 5 (25%). Distribution of patients by cancer 
cancer stage and hydronephrosis status are shown in 
table I.
Table I. Distribution ot patients by cancer stage and 
hydronephrosis status
Stage
Unilateral
(n.%)
Hydronephrosis
Bilateral
(n.%)
Overall
(n,%)
pT1 30 (55) - 30 (40)
pT2 10 (18) 10 (50) 20 (27)
pT3 15(27) 5(25) 20 (27)
pT4 5(25) 5(6)
Totals 55 20 75
DISCUSSION
Appropriate and accurate tumor staging is an 
underlying principle of modern surgical oncology. 
Because tumor stage is important in determining 
therapy, accurate staging of bladder cancer is 
desirable. Nevertheless, there are considerable 
staging erros in bladder cancer. Bladder cancer is 
most accurately staged by transurethral resection of 
the bladder lesion. Imaging tests such as ultrasound, 
computed tomography (CT), and magnetic resonance 
imaging (MRI) tend to overstage superficial disease. 
Bimanual examination may help to identify the 
potential of resectability by determining pelvic wall 
fixation. It has little discriminatory value for localized or 
superficial lesions (2,3,6).
Excretory urography is indicated in all patients with 
hematuria or cystoscopic evidence of bladder cancer. 
Some investigators have reported the association of 
ureteral obstruction and advanced stage carcinoma of 
the bladder (7-11). But, the accuracy of this finding in 
predicting advanced stage disease is unclear (12-14). 
Nichols and Marshall first reported the association of 
ureteral obstruction with grade and stage of bladder 
cancer. Of their patients with ureteral obstruction 70% 
had high stage, high grade lesions (7). Hatch et al 
found that 35 (92%) of 38 patients with bladder tumor 
who had ureteral obstruction had muscle-invasive 
tumors (11). For bilharzial bladder cancer, ureteral 
obstruction proved much less specific, as 83% of the 
patients with superficial disease demonstrated this 
finding (14). A series by Lang revealed that only 7 of 
8 8  patients with pathologic stage B disease had 
ureteral obstruction or renal nonfunction on excretory 
urogram, with a sensitivity of 8 % (8 ). Most studies 
investigating obstruction and cancer stage have not 
distinguished unilateral from bilateral obstruction
(8,11). Recently, Haleblian et al found that more than 
90% of patients with bilateral obstuction had disease 
with extravesical extension. Of the patients with 
unilateral obstruction one third of them had disease 
confined to the bladder with a significant proportion 
confined to the bladder mucosa (10). Our results 
showed that among the patients with hydronephrosis 
60% had advanced stage tumors. Bilateral 
hydronephrosis was a strong predictor because all of 
these patients had advanced stage disease. Unilateral 
hydronephrosis was associated with advanced stage 
disease in 45% of the cases.
Finally, IVP can be used in staging since 
hydronephrosis may indicate the presence of a 
muscle-invasive bladder cancer. Especially, bilateral 
hydronephrosis was strongly associated with 
advanced stage disease.
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